Company intelligence / Profile preview

GCM Citrus

Ownership: Private
Development stage: Commercial

Overview

GCM Citrus specializes in the research, development, and commercialization of innovative citrus varieties. The company uses both traditional plant breeding and advanced biotechnological techniques to create new seedless mandarin varieties and other improved citrus cultivars. It operates certified nurseries, collaborates with leading academic institutions, and manages global licensing for its proprietary varieties[1][3][5].

Therapeutic areas: Other
Modalities: Not applicable (focus is on plant breeding, not therapeutic modalities)
Industry: Agriculture & AgTech

Partnerships

IBMCP-CSIC (Dr. Leandro Peña’s laboratory)IVIA (Dr. Pablo Aleza’s laboratory)[5]Collaborations with public/private research centers, universities, production & marketing companies[1][3][5]

Beyond the preview

Go deeper on GCM Citrus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GCM Citrus.

Explore the full profile